Ocular Therapeutix Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
38.59 M |
Public Float |
31.96 M |
Ocular Therapeutix Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.63 |
Market Cap |
$220.61 M |
Shares Outstanding |
42.84 M |
Public Float |
34.79 M |
Address |
15 Crosby Drive Bedford Massachusetts 01730 United States |
Employees | - |
Website | http://www.ocutx.com |
Updated | 07/08/2019 |
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. |